Загрузка...
In silico Exploration of Inhibitors for SARS-CoV-2's Papain-Like Protease
Coronavirus disease 2019 (COVID-19) is an ongoing global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with very limited treatments so far. Demonstrated with good druggability, two major proteases of SARS-CoV-2, namely main protease (Mpro) and papain-like protease...
Сохранить в:
| Опубликовано в: : | Front Chem |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7889802/ https://ncbi.nlm.nih.gov/pubmed/33614597 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fchem.2020.624163 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|